Imiquimod can induce notable DC maturation after binding to TLR7 and promote DC migration from skin to draining lymph nodes, enhancing tumor-specific cytotoxic CD8 + T cells and macrophage activation [226]. This evidence concerns the gene CD8A and neoplasm.